Amphastar Pharmaceuticals
AMPH
270 hedge funds and large institutions have $1.47B invested in Amphastar Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 89 increasing their positions, 98 reducing their positions, and 53 closing their positions.
21% more call options, than puts
Call options by funds: $3.17M | Put options by funds: $2.61M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
9% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 98
2% less funds holding
Funds holding: 276 → 270 (-6)
3.26% less ownership
Funds ownership: 73.03% → 69.78% (-3.3%)
11% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 53
32% less capital invested
Capital invested by funds: $2.16B → $1.47B (-$691M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$14.5M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.6M |
| 3 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$11.2M |
| 4 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$10.7M |
| 5 |
EIP
Epoch Investment Partners
New York
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$89.2M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$61.8M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$8.02M |
| 4 |
BHWA
Beacon Harbor Wealth Advisors
Virginia Beach,
Virginia
|
-$6.38M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$4.79M |
AMPH Hedge Fund Activity: Q1 2024 in Review
270 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q1 2024, worth a combined $1.47B — down 32% from $2.16B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of AMPH and 47 opened new positions — a net loss of 6 holders — while 98 trimmed existing stakes and 89 added.
The largest buyer was American Century Companies, adding an estimated $14.5M. The largest seller was Neuberger Berman Group, cutting an estimated $89.2M.
- 270 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q1 2024, down from 276 in Q4 2023.
- Funds reported $1.47B of Amphastar Pharmaceuticals stock for Q1 2024, down 32% quarter-over-quarter.
- 47 funds opened new Amphastar Pharmaceuticals positions in Q1 2024 and 53 closed out, a net change of -6 holders.
- The largest Amphastar Pharmaceuticals buyer in Q1 2024 was American Century Companies, an estimated $14.5M added.
- The largest Amphastar Pharmaceuticals seller in Q1 2024 was Neuberger Berman Group, an estimated $89.2M sold.
Based on aggregated 13F filings for Q1 2024.